Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> Moeller KE, et al. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens. <i>Mayo Clin Proc.</i> 2017 May;92(5):774-796. <a href=https://www.mayoclinicproceedings.org/action/showPdf?pii=S0025-6196%2816%2930825-4><u>Free, full-text PDF</u></a>
<br><br>
• Passive marijuana exposure resulted in THC metabolite urine concentrations below standard cutoffs
<br><br>
• Passive marijuana exposure resulted in THC metabolite urine concentrations below standard cutoffs
Detail Type
Text
Patient Type Detail Header (Long)
Cannabinoid immunoassay screens for THC metabolite 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid; synthetic cannabinoids in spice, K2 will not be detected w/ this test.<br><br>